Evolent Health, Inc $EVH Holdings Boosted by Northern Trust Corp

Northern Trust Corp boosted its position in shares of Evolent Health, Inc (NYSE:EVH) by 0.7% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,203,501 shares of the technology company’s stock after purchasing an additional 8,637 shares during the period. Northern Trust Corp owned 1.03% of Evolent Health worth $11,397,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Banque Cantonale Vaudoise acquired a new stake in shares of Evolent Health during the 1st quarter valued at $25,000. US Bancorp DE raised its holdings in Evolent Health by 291.0% in the 1st quarter. US Bancorp DE now owns 5,153 shares of the technology company’s stock worth $49,000 after acquiring an additional 3,835 shares during the period. Signaturefd LLC raised its holdings in Evolent Health by 400.6% in the 1st quarter. Signaturefd LLC now owns 7,043 shares of the technology company’s stock worth $67,000 after acquiring an additional 5,636 shares during the period. GAMMA Investing LLC raised its holdings in Evolent Health by 5,036.4% in the 1st quarter. GAMMA Investing LLC now owns 9,451 shares of the technology company’s stock worth $90,000 after acquiring an additional 9,267 shares during the period. Finally, State of Wyoming bought a new position in Evolent Health in the 4th quarter worth $95,000.

Evolent Health Stock Performance

Shares of EVH stock opened at $9.49 on Friday. The stock has a market cap of $1.11 billion, a P/E ratio of -5.89 and a beta of 0.73. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.01 and a quick ratio of 1.01. The company has a fifty day moving average price of $10.07 and a two-hundred day moving average price of $9.54. Evolent Health, Inc has a one year low of $7.06 and a one year high of $31.80.

Evolent Health (NYSE:EVH) last announced its quarterly earnings results on Thursday, August 7th. The technology company reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.20). The firm had revenue of $444.33 million during the quarter, compared to analyst estimates of $459.43 million. Evolent Health had a negative net margin of 5.94% and a positive return on equity of 1.83%. The business’s revenue was down 31.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.30 EPS. Evolent Health has set its Q3 2025 guidance at EPS. As a group, equities analysts predict that Evolent Health, Inc will post 0.08 EPS for the current year.

Analyst Ratings Changes

Several research firms have recently issued reports on EVH. UBS Group boosted their price objective on shares of Evolent Health from $14.00 to $15.00 and gave the stock a “buy” rating in a report on Friday, May 9th. Piper Sandler boosted their price target on shares of Evolent Health from $16.00 to $18.00 and gave the company an “overweight” rating in a research report on Thursday, August 28th. Truist Financial upped their target price on shares of Evolent Health from $14.00 to $16.00 and gave the stock a “buy” rating in a research report on Thursday, July 17th. JMP Securities reiterated a “market outperform” rating and set a $13.00 target price on shares of Evolent Health in a research report on Friday, June 20th. Finally, Needham & Company LLC reissued a “buy” rating and set a $15.00 price target on shares of Evolent Health in a research note on Tuesday, May 13th. One analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $18.07.

About Evolent Health

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.